CSNK1E and breast carcinoma: CSNK1E encodes a beta-catenin destruction complex and is involved in aberrations of the Wnt/beta-catenin signaling pathway, which lead to beta-catenin oncoprotein accumulation in the nucleus [52,53]; elevated expression in breast cancer patients with relapses was observed in the current study (Figure S4).